TY - JOUR
T1 - Rare Cutaneous Malignancies in Skin of Color
AU - Mosallaei, Daniel
AU - Lee, Erica B.
AU - Lobl, Marissa
AU - Clarey, Dillon
AU - Wysong, Ashley
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - BACKGROUNDThere is a scarcity of information regarding the clinical characteristics of rare cutaneous malignancies in skin of color that has yet to be comprehensively explored.OBJECTIVETo review and compile the racial differences in epidemiology, clinical presentation, histology, treatments, and outcomes of 3 rare skin cancers: dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC).METHODSSeveral searches with keywords denoting specific skin cancer type and race were conducted on PubMed to complete this narrative review.RESULTSWe analyzed 50 sources that were relevant to the initial objective.CONCLUSIONThe literature demonstrates that there are nuances in DFSP, MCC, and SC unique to African Americans, Asians/Pacific Islanders, and Hispanics that may differ significantly from Caucasian counterparts. African Americans consistently suffer from the worst clinical outcomes in all 3 rare cutaneous malignancies reviewed. Greater physician awareness and knowledge of the discussed racial differences is the preliminary step to address these disparities.
AB - BACKGROUNDThere is a scarcity of information regarding the clinical characteristics of rare cutaneous malignancies in skin of color that has yet to be comprehensively explored.OBJECTIVETo review and compile the racial differences in epidemiology, clinical presentation, histology, treatments, and outcomes of 3 rare skin cancers: dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC).METHODSSeveral searches with keywords denoting specific skin cancer type and race were conducted on PubMed to complete this narrative review.RESULTSWe analyzed 50 sources that were relevant to the initial objective.CONCLUSIONThe literature demonstrates that there are nuances in DFSP, MCC, and SC unique to African Americans, Asians/Pacific Islanders, and Hispanics that may differ significantly from Caucasian counterparts. African Americans consistently suffer from the worst clinical outcomes in all 3 rare cutaneous malignancies reviewed. Greater physician awareness and knowledge of the discussed racial differences is the preliminary step to address these disparities.
UR - http://www.scopus.com/inward/record.url?scp=85131270943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131270943&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000003440
DO - 10.1097/DSS.0000000000003440
M3 - Review article
C2 - 35384892
AN - SCOPUS:85131270943
SN - 1076-0512
VL - 48
SP - 606
EP - 612
JO - Journal of Dermatologic Surgery and Oncology
JF - Journal of Dermatologic Surgery and Oncology
IS - 6
ER -